MSTC Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 4, 2025, 3:15 am

Quick Insight

MSTC Ltd, a Trading & Distributors company, currently trades at ₹510 with a market capitalization of ₹3,593 Cr. The company's P/E ratio stands at 16.5, reflecting a reasonable valuation compared to industry peers. MSTC boasts a robust Return on Equity (ROE) of 28.4% and Return on Capital Employed (ROCE) of 29.3%, indicating efficient utilization of capital. With an Operating Profit Margin (OPM) of 56%, the company demonstrates strong operational efficiency. Additionally, MSTC's Interest Coverage Ratio (ICR) of 901.97x signifies a comfortable position to service its debt obligations.

Despite these strengths, MSTC faces risks such as a high Price-to-Book Value (P/BV) ratio of 6.58x, which may indicate an overvalued stock compared to industry norms. The company's Cash Conversion Cycle (CCC) of 363 days raises concerns about working capital management efficiency. Moving forward, MSTC could enhance its outlook by improving working capital management to shorten the CCC, thereby boosting cash flows. Furthermore, diversifying its shareholder base beyond the current high promoter holding of 64.75% could enhance market confidence and liquidity in the stock.

In conclusion, while MSTC demonstrates strong financial performance metrics, investors should closely monitor working capital efficiency and shareholder diversification to mitigate risks and capitalize on the company's growth potential.

Competitors of MSTC Ltd

All Competitor Stocks of MSTC Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:35 am

Below is a detailed analysis of the quarterly data for MSTC Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 77.00 Cr.. The value appears to be declining and may need further review. It has decreased from 89.00 Cr. (Mar 2025) to 77.00 Cr., marking a decrease of 12.00 Cr..
• For Expenses, as of Jun 2025, the value is 34.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 36.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 2.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Mar 2025) to 44.00 Cr., marking a decrease of 9.00 Cr..
• For OPM %, as of Jun 2025, the value is 56.00%. The value appears to be declining and may need further review. It has decreased from 59.00% (Mar 2025) to 56.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 64.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 6.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from -19.00% (Mar 2025) to 27.00%, marking an increase of 46.00%.
• For Net Profit, as of Jun 2025, the value is 42.00 Cr.. The value appears to be declining and may need further review. It has decreased from 76.00 Cr. (Mar 2025) to 42.00 Cr., marking a decrease of 34.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.01. The value appears to be declining and may need further review. It has decreased from 10.73 (Mar 2025) to 6.01, marking a decrease of 4.72.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:53 pm

Growth

Last Updated: September 5, 2025, 10:00 am

Balance Sheet

Last Updated: June 16, 2025, 11:46 am

Below is a detailed analysis of the balance sheet data for MSTC Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 70.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 70.00 Cr..
• For Reserves, as of Mar 2025, the value is 668.00 Cr.. The value appears to be declining and may need further review. It has decreased from 819.00 Cr. (Mar 2024) to 668.00 Cr., marking a decrease of 151.00 Cr..
• For Borrowings, as of Mar 2025, the value is 145.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 145.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,235.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,216.00 Cr. (Mar 2024) to 1,235.00 Cr., marking an increase of 19.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,118.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,250.00 Cr. (Mar 2024) to 2,118.00 Cr., marking a decrease of 132.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 65.00 Cr.. The value appears to be declining and may need further review. It has decreased from 150.00 Cr. (Mar 2024) to 65.00 Cr., marking a decrease of 85.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,042.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,087.00 Cr. (Mar 2024) to 2,042.00 Cr., marking a decrease of 45.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,118.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,250.00 Cr. (Mar 2024) to 2,118.00 Cr., marking a decrease of 132.00 Cr..

Notably, the Reserves (668.00 Cr.) exceed the Borrowings (145.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for MSTC Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 29.03. This value is within the healthy range. It has decreased from 34.37 (Mar 23) to 29.03, marking a decrease of 5.34.
• For Diluted EPS (Rs.), as of Mar 24, the value is 29.03. This value is within the healthy range. It has decreased from 34.37 (Mar 23) to 29.03, marking a decrease of 5.34.
• For Cash EPS (Rs.), as of Mar 24, the value is 33.44. This value is within the healthy range. It has decreased from 37.85 (Mar 23) to 33.44, marking a decrease of 4.41.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 126.28. It has increased from 111.72 (Mar 23) to 126.28, marking an increase of 14.56.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 126.28. It has increased from 111.72 (Mar 23) to 126.28, marking an increase of 14.56.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 106.65. It has increased from 102.41 (Mar 23) to 106.65, marking an increase of 4.24.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 52.78. This value is within the healthy range. It has increased from 50.25 (Mar 23) to 52.78, marking an increase of 2.53.
• For PBIT / Share (Rs.), as of Mar 24, the value is 49.35. This value is within the healthy range. It has increased from 47.15 (Mar 23) to 49.35, marking an increase of 2.20.
• For PBT / Share (Rs.), as of Mar 24, the value is 49.30. This value is within the healthy range. It has increased from 47.13 (Mar 23) to 49.30, marking an increase of 2.17.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 30.00. This value is within the healthy range. It has decreased from 34.74 (Mar 23) to 30.00, marking a decrease of 4.74.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 29.03. This value is within the healthy range. It has decreased from 34.37 (Mar 23) to 29.03, marking a decrease of 5.34.
• For PBDIT Margin (%), as of Mar 24, the value is 49.49. This value is within the healthy range. It has increased from 49.06 (Mar 23) to 49.49, marking an increase of 0.43.
• For PBIT Margin (%), as of Mar 24, the value is 46.27. This value exceeds the healthy maximum of 20. It has increased from 46.03 (Mar 23) to 46.27, marking an increase of 0.24.
• For PBT Margin (%), as of Mar 24, the value is 46.22. This value is within the healthy range. It has increased from 46.02 (Mar 23) to 46.22, marking an increase of 0.20.
• For Net Profit Margin (%), as of Mar 24, the value is 28.13. This value exceeds the healthy maximum of 10. It has decreased from 33.92 (Mar 23) to 28.13, marking a decrease of 5.79.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 27.21. This value exceeds the healthy maximum of 20. It has decreased from 33.56 (Mar 23) to 27.21, marking a decrease of 6.35.
• For Return on Networth / Equity (%), as of Mar 24, the value is 22.98. This value is within the healthy range. It has decreased from 30.76 (Mar 23) to 22.98, marking a decrease of 7.78.
• For Return on Capital Employeed (%), as of Mar 24, the value is 34.81. This value is within the healthy range. It has decreased from 37.21 (Mar 23) to 34.81, marking a decrease of 2.40.
• For Return On Assets (%), as of Mar 24, the value is 9.08. This value is within the healthy range. It has increased from 8.99 (Mar 23) to 9.08, marking an increase of 0.09.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.16. This value is within the healthy range. It has decreased from 0.18 (Mar 23) to 0.16, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.30. There is no change compared to the previous period (Mar 23) which recorded 0.30.
• For Current Ratio (X), as of Mar 24, the value is 1.39. This value is below the healthy minimum of 1.5. It has increased from 1.24 (Mar 23) to 1.39, marking an increase of 0.15.
• For Quick Ratio (X), as of Mar 24, the value is 1.39. This value is within the healthy range. It has increased from 1.24 (Mar 23) to 1.39, marking an increase of 0.15.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 36.16. This value is within the healthy range. It has decreased from 47.13 (Mar 23) to 36.16, marking a decrease of 10.97.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 32.34. This value is within the healthy range. It has decreased from 43.23 (Mar 23) to 32.34, marking a decrease of 10.89.
• For Earning Retention Ratio (%), as of Mar 24, the value is 63.84. This value is within the healthy range. It has increased from 52.87 (Mar 23) to 63.84, marking an increase of 10.97.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 67.66. This value is within the healthy range. It has increased from 56.77 (Mar 23) to 67.66, marking an increase of 10.89.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 901.97. This value is within the healthy range. It has decreased from 3,870.45 (Mar 23) to 901.97, marking a decrease of 2,968.48.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 513.71. This value is within the healthy range. It has decreased from 2,677.27 (Mar 23) to 513.71, marking a decrease of 2,163.56.
• For Enterprise Value (Cr.), as of Mar 24, the value is 4,848.00. It has increased from 324.59 (Mar 23) to 4,848.00, marking an increase of 4,523.41.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 6.46. This value exceeds the healthy maximum of 3. It has increased from 0.45 (Mar 23) to 6.46, marking an increase of 6.01.
• For EV / EBITDA (X), as of Mar 24, the value is 13.05. This value is within the healthy range. It has increased from 0.91 (Mar 23) to 13.05, marking an increase of 12.14.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 7.79. This value exceeds the healthy maximum of 3. It has increased from 2.47 (Mar 23) to 7.79, marking an increase of 5.32.
• For Retention Ratios (%), as of Mar 24, the value is 63.83. This value is within the healthy range. It has increased from 52.86 (Mar 23) to 63.83, marking an increase of 10.97.
• For Price / BV (X), as of Mar 24, the value is 6.58. This value exceeds the healthy maximum of 3. It has increased from 2.26 (Mar 23) to 6.58, marking an increase of 4.32.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 7.79. This value exceeds the healthy maximum of 3. It has increased from 2.47 (Mar 23) to 7.79, marking an increase of 5.32.
• For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 23) to 0.03, marking a decrease of 0.10.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness